Calcium: safety and interactions
Limits on total intake, tolerability and intervals with medicines.
Key points
- Calcium supplements can cause constipation, bloating and gas. In chronic kidney disease, calcium amount and the need for a supplement are determined individually. [1] [2] [3] See the evidence 1 2
- The US upper level of total calcium intake is 2,500 mg daily at ages 19–50 and 2,000 mg from age 51. This is a limit for all sources, not an intake target. [2] See the evidence 1
- Calcium can interfere with absorption of some medicines, including levothyroxine and ciprofloxacin. The interval depends on the medicine; check the schedule against its instructions and with a doctor or pharmacist. [2] [4] [5] See the evidence 1 2 3
- In a study of postmenopausal women, urinary tract stones were diagnosed more often with calcium plus vitamin D than with placebo over an average of seven years. The result applies to this combination. [6] See the evidence 1
Practical guide
Check the conclusions and whether they apply to your situation.
Account for calcium from all sources and check interactions of specific medicines.
Key points
Why these conclusions
Tolerability, limits and medicines
Constipation, bloating and gas are possible. In a pooled analysis of seven studies, various gastrointestinal complaints were reported by 716 of 5,082 participants on calcium and 506 of 5,046 in comparison groups; this is not the frequency of constipation alone. [1] [2]
The US upper level from all sources is 2,500 mg at ages 19–50 and 2,000 mg from age 51; for children it depends on age. In chronic kidney disease, calcium amount and the need for a supplement are determined individually. [2] [3]
Take calcium carbonate and levothyroxine at least four hours apart. Take ciprofloxacin tablets at least two hours before the calcium supplement or no earlier than six hours afterward; check the instructions for another antibiotic. [2] [4]
Tivicay or Tivicay PD may be taken with calcium at the same time with food; without food, take the medicine at least two hours before calcium or six hours afterward. Do not change the prescribed regimen without a doctor. [2] [5]
A meta-analysis found no statistically significant increase in heart attack frequency with calcium alone or calcium plus vitamin D; a possible increased risk cannot be excluded, and another meta-analysis obtained a different result for calcium. In a study of postmenopausal women taking 1,000 mg calcium and 400 IU vitamin D daily, urinary tract stones were reported by 449 of 18,176 versus 381 of 18,106 on placebo over an average of seven years. [7] [8] [6]
Calcium supplements can cause constipation, bloating and gas. In a pooled analysis of seven studies, gastrointestinal complaints were reported by 716 of 5,082 participants in calcium groups and 506 of 5,046 in comparison groups; this combines complaints and is not the frequency of constipation. In one study calcium was taken both with and without vitamin D.
Calcium supplements can cause constipation, bloating and gas. In a pooled analysis of seven studies, gastrointestinal complaints were reported by 716 of 5,082 participants in calcium groups and 506 of 5,046 in comparison groups; this combines complaints and is not the frequency of constipation. In one study calcium was taken both with and without vitamin D. [1] [2]
In the US, the tolerable upper intake level of elemental calcium from all sources is 2,500 mg daily at ages 19–50 and 2,000 mg from age 51. This is an upper limit, not a target. Hypercalcemia can be accompanied by constipation, nausea, impaired kidney function and heart rhythm disturbances.
In the US, the tolerable upper intake level of elemental calcium from all sources is 2,500 mg daily at ages 19–50 and 2,000 mg from age 51. This is an upper limit, not a target. Hypercalcemia can be accompanied by constipation, nausea, impaired kidney function and heart rhythm disturbances. [2]
In the US, the tolerable upper intake level of calcium from food, drinks and supplements for children is 1,000 mg/day at 0–6 months, 1,500 mg/day at 7–12 months, 2,500 mg/day at ages 1–8 and 3,000 mg/day at 9–18. These are not recommended supplement doses.
In the US, the tolerable upper intake level of calcium from food, drinks and supplements for children is 1,000 mg/day at 0–6 months, 1,500 mg/day at 7–12 months, 2,500 mg/day at ages 1–8 and 3,000 mg/day at 9–18. These are not recommended supplement doses. [2]
In chronic kidney disease, calcium amount and the need for a supplement are determined individually.
In chronic kidney disease, calcium amount and the need for a supplement are determined individually. [3]
Levothyroxine, such as Synthroid: Calcium carbonate can reduce levothyroxine absorption. Take levothyroxine and calcium carbonate supplements at least 4 hours apart; check the schedule against the prescribed medicine’s instructions.
Levothyroxine, such as Synthroid: Calcium carbonate can reduce levothyroxine absorption. Take levothyroxine and calcium carbonate supplements at least 4 hours apart; check the schedule against the prescribed medicine’s instructions. [2]
Ciprofloxacin tablets, a quinolone antibiotic: Calcium can reduce ciprofloxacin absorption when taken together. According to the cited ciprofloxacin tablet instructions, take the antibiotic at least 2 hours before the calcium supplement or no earlier than 6 hours afterward; check the specific instructions for another quinolone.
Ciprofloxacin tablets, a quinolone antibiotic: Calcium can reduce ciprofloxacin absorption when taken together. According to the cited ciprofloxacin tablet instructions, take the antibiotic at least 2 hours before the calcium supplement or no earlier than 6 hours afterward; check the specific instructions for another quinolone. [2] [4]
Dolutegravir: Tivicay or Tivicay PD: A calcium supplement taken simultaneously on an empty stomach can substantially lower blood dolutegravir concentrations. Tivicay or Tivicay PD may be taken at the same time as a calcium supplement with food; without food, take Tivicay or Tivicay PD at least 2 hours before calcium or 6 hours afterward. Do not change the prescribed regimen without a doctor.
Dolutegravir: Tivicay or Tivicay PD: A calcium supplement taken simultaneously on an empty stomach can substantially lower blood dolutegravir concentrations. Tivicay or Tivicay PD may be taken at the same time as a calcium supplement with food; without food, take Tivicay or Tivicay PD at least 2 hours before calcium or 6 hours afterward. Do not change the prescribed regimen without a doctor. [2] [5]
In the 2023 meta-analysis by Huo and colleagues, calcium without vitamin D did not show a statistically significant increase in heart attack frequency: RR 1.15 (95% CI 0.88–1.51). A possible increased risk cannot be excluded. The 2021 meta-analysis by Myung and colleagues obtained a different result.
| Parameter | Data |
|---|---|
| Result | In the 2023 meta-analysis by Huo and colleagues, calcium without vitamin D did not show a statistically significant increase in heart attack frequency: RR 1.15 (95% CI 0.88–1.51). A possible increased risk cannot be excluded. The 2021 meta-analysis by Myung and colleagues obtained a different result. |
| Participants | Participants in randomized comparisons of calcium alone with control: 8,634 people in total; 219 heart attacks is the number of events in the analysis, not participants. |
| Form | Calcium alone |
| Dose | Mean dose 1 g/day |
| Dose basis | Mean dose 1 g/day |
| Comparator | Control |
| Duration | Different RCT durations |
| Confidence | 2/4: Heart attack was often not the primary outcome; criteria and extraction differed.; No significant between-study inconsistency for the conclusion was established or the estimate is from one study.; The conclusion is limited to the directly studied outcome and population.; The CI is compatible with both no effect and increased risk.; No grounds for a separate downgrade. |
| Evidence base | Huo 2023: 7 randomized comparisons of calcium alone with control; the Myung 2021 review with overlapping studies is also cited. These are not 2 separate trials. |
| Sources | [7] [8] |
In the 2023 meta-analysis by Huo and colleagues, calcium plus vitamin D did not show a statistically significant increase in heart attack frequency: RR 1.09 (95% CI 0.95–1.25). The result applies to the combination; a possible increased risk cannot be excluded.
| Parameter | Data |
|---|---|
| Result | In the 2023 meta-analysis by Huo and colleagues, calcium plus vitamin D did not show a statistically significant increase in heart attack frequency: RR 1.09 (95% CI 0.95–1.25). The result applies to the combination; a possible increased risk cannot be excluded. |
| Participants | Participants in randomized comparisons of calcium plus vitamin D with control: 46,804 people in total; 854 heart attacks is the number of events in the analysis. Most participants and events were from WHI. |
| Form | Calcium with vitamin D |
| Dose | Doses varied |
| Dose basis | Doses varied |
| Comparator | Control |
| Duration | Different RCT durations |
| Confidence | 2/4: Heart attack was often not the primary outcome; criteria and extraction differed.; No significant between-study inconsistency for the conclusion was established or the estimate is from one study.; The conclusion is limited to the directly studied outcome and population.; The CI is compatible with both no effect and increased risk.; No grounds for a separate downgrade. |
| Evidence base | Huo 2023: 6 randomized comparisons of calcium plus vitamin D with control; the Myung 2021 review with overlapping studies is also cited. These comparisons cannot be added to calcium alone as independent trials. |
| Sources | [7] [8] |
In the WHI study, 36,282 postmenopausal women received 1,000 mg elemental calcium as carbonate and 400 IU vitamin D daily or placebo. Over an average of 7 years, diagnosed urinary tract stones were reported by 449 of 18,176 and 381 of 18,106 women respectively; HR 1.17 (95% CI 1.02–1.34). The result applies to calcium plus vitamin D.
| Parameter | Data |
|---|---|
| Result | In the WHI study, 36,282 postmenopausal women received 1,000 mg elemental calcium as carbonate and 400 IU vitamin D daily or placebo. Over an average of 7 years, diagnosed urinary tract stones were reported by 449 of 18,176 and 381 of 18,106 women respectively; HR 1.17 (95% CI 1.02–1.34). The result applies to calcium plus vitamin D. |
| Participants | 36,282 postmenopausal women aged 50–79 |
| Form | Calcium carbonate with vitamin D3 |
| Dose | 1,000 mg elemental calcium and 400 IU D3/day |
| Dose basis | 1,000 mg elemental calcium and 400 IU D3/day |
| Comparator | Placebo |
| Duration | Average 7 years |
| Confidence | 2/4: Self-report of a clinical diagnosis, incomplete adherence.; No significant between-study inconsistency for the conclusion was established or the estimate is from one study.; The conclusion is limited to the directly studied outcome and population.; The CI permits a very small increase.; No grounds for a separate downgrade. |
| Evidence base | 1 randomized WHI trial; 1 named publication on this outcome. |
| Sources | [6] |
More details
Check total dose
The upper level refers to calcium from food, drinks and supplements combined; children’s age-specific limits are not recommended supplement doses. [2]
Sources
- Adverse events from calcium supplementation: Relationship to errors in myocardial infarction self-reporting in randomized controlled trials of calcium supplementation. https://onlinelibrary.wiley.com/doi/abs/10.1002/jbmr.1484
- Calcium - Health Professional Fact Sheet. https://ods.od.nih.gov/factsheets/Calcium-HealthProfessional/
- KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD) — recommendation statements. https://kdigo.org/wp-content/uploads/2017/02/KDIGO_CKD_MBD_Guideline_r6.pdf
- CIPROFLOXACIN tablet, film coated — prescribing information. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fa32aafd-e3f5-4be6-9413-c7663c1c2cec
- TIVICAY and TIVICAY PD — prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/213983s007lbl.pdf
- Urinary tract stone occurrence in the Women's Health Initiative (WHI) randomized clinical trial of calcium and vitamin D supplements. https://pmc.ncbi.nlm.nih.gov/articles/PMC3127502/
- Calcium Supplements and Risk of CVD: A Meta-Analysis of Randomized Trials. https://pmc.ncbi.nlm.nih.gov/articles/PMC10111600/
- Calcium Supplements and Risk of Cardiovascular Disease: A Meta-Analysis of Clinical Trials. https://pmc.ncbi.nlm.nih.gov/articles/PMC7910980/
Methodology: Subpages evidence-led supplement pipeline v1